Guanidine derivatives useful in therapy as inhibitors of nitric oxide synthetase
US5998399A · kind A · utility
0Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 1998 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Nov 16, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Method of treating or reducing the risk of human disease or condition in which the synthesis or oversynthesis of nitric oxide forms a contributory part wherein a therapeutically effective amount of the compound of formula (I) as defined in the specification is administered to a person suffering from or susceptible to such disease or condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.